For more than 75 years, Kerry has provided integrated solutions for the world’s leading biotechnology customers. We provide cell nutrition supplements including protein hydrolysates, yeast extracts, recombinant proteins, cell line tailored supplement systems and chemically defined medium. We deliver innovative solutions to assist customers maximize yields and cell performance in biotechnological production systems.
Session Spotlight Sponsor
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit SyneosHealth.com.
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world’s most pressing and evolving health needs. Our innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes. We are more than 45,000 associates in 50 countries who strive to fulfill our purpose of helping all people live healthy lives; by advancing the quality, accessibility, safety and affordability of healthcare around the world. In 2015, BD welcomed CareFusion and its products into the BD family of solutions. For more information on BD, please visit bd.com.
北京西美杰科技有限公司是美国Pfanstiehl的中国总代理。Pfanstiehl拥有100年历史，专注于生产符合cGMP、ICH Q7A、ICH Q3D及多国药典(USP/NF, EP, JP, ChP)的高纯低内毒素注射级糖类辅料，主要产品有海藻糖、蔗糖、半乳糖、甘露醇、山梨醇等，更多辅料陆续上市。其中海藻糖、蔗糖已在CDE注册登记，其余产品注册工作陆续启动，按照最新法规要求全面配合关联审评。目前全球经FDA审批已上市的生物药中，Pfanstiehl的产品被用作最主要的辅料。西美杰同时为药企提供Kerry细胞培养添加物、Cygnus HCP检测试剂盒等。